These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 20380649)

  • 1. Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature.
    Nalysnyk L; Hernandez-Medina M; Krishnarajah G
    Diabetes Obes Metab; 2010 Apr; 12(4):288-98. PubMed ID: 20380649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes.
    Smith-Palmer J; Brändle M; Trevisan R; Orsini Federici M; Liabat S; Valentine W
    Diabetes Res Clin Pract; 2014 Sep; 105(3):273-84. PubMed ID: 25023992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes.
    Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():3-8. PubMed ID: 24034513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood glucose control and microvascular and macrovascular complications in diabetes.
    Hanssen KF
    Diabetes; 1997 Sep; 46 Suppl 2():S101-3. PubMed ID: 9285509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. For debate. Glucose variability and diabetes complication risk: we need to know the answer.
    Kilpatrick ES; Rigby AS; Atkin SL
    Diabet Med; 2010 Aug; 27(8):868-71. PubMed ID: 20653742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocentric risk factors for macrovascular complications in diabetes: Glucose 'legacy' and 'variability'-what we see, know and try to comprehend.
    Monnier L; Colette C; Schlienger JL; Bauduceau B; R Owens D
    Diabetes Metab; 2019 Oct; 45(5):401-408. PubMed ID: 30685425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycemic variability in type 2 diabetes mellitus: oxidative stress and macrovascular complications.
    Johnson EL
    Adv Exp Med Biol; 2012; 771():139-54. PubMed ID: 23393677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What does postprandial hyperglycaemia mean?
    Heine RJ; Balkau B; Ceriello A; Del Prato S; Horton ES; Taskinen MR
    Diabet Med; 2004 Mar; 21(3):208-13. PubMed ID: 15008828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of blood glucose concentrations on the development of chronic complications of diabetes mellitus.
    Swidan SZ; Montgomery PA
    Pharmacotherapy; 1998; 18(5):961-72. PubMed ID: 9758308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic Control and Excess Cardiovascular Mortality in Type 1 Diabetes.
    Teleb M; Popp Switzer M; Elhanafi S; Elfar A; San Juan ZT
    Curr Cardiol Rep; 2016 Mar; 18(3):29. PubMed ID: 26886228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of basal and post-prandial hyperglycaemia to micro- and macrovascular complications in people with type 2 diabetes.
    Home P
    Curr Med Res Opin; 2005 Jul; 21(7):989-98. PubMed ID: 16004665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus in older patients. Is tight blood glucose control warranted?
    Lunt H
    Drugs Aging; 1996 Jun; 8(6):401-7. PubMed ID: 8736623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of intensive versus conventional glucose control on microvascular and macrovascular complications in type 1 and 2 diabetes mellitus.
    Mattila TK; de Boer A
    Drugs; 2010 Dec; 70(17):2229-45. PubMed ID: 21080740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose variability, blood pressure and arterial stiffness in type 1 diabetes.
    Gordin D; Rönnback M; Forsblom C; Mäkinen V; Saraheimo M; Groop PH
    Diabetes Res Clin Pract; 2008 Jun; 80(3):e4-7. PubMed ID: 18325620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
    Sjöholm A
    Lakartidningen; 2001 Feb; 98(9):937-40. PubMed ID: 11292972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycemic variability and diabetes retinopathy: a missing link.
    Hsu CR; Chen YT; Sheu WH
    J Diabetes Complications; 2015 Mar; 29(2):302-6. PubMed ID: 25534877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The assessment of glycemic variability and its impact on diabetes-related complications: an overview.
    Weber C; Schnell O
    Diabetes Technol Ther; 2009 Oct; 11(10):623-33. PubMed ID: 19821754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis.
    Gorst C; Kwok CS; Aslam S; Buchan I; Kontopantelis E; Myint PK; Heatlie G; Loke Y; Rutter MK; Mamas MA
    Diabetes Care; 2015 Dec; 38(12):2354-69. PubMed ID: 26604281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Issues surrounding tight glycemic control in people with type 2 diabetes mellitus.
    Cerveny JD; Leder RD; Weart CW
    Ann Pharmacother; 1998 Sep; 32(9):896-905. PubMed ID: 9762378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.